FDA Inspection 1147799 — David R. Spigel, M.D.
The FDA completed an inspection of David R. Spigel, M.D. on June 28, 2021 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 28, 2021
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Clinical Investigator (CI)